查找临床试验
已按「白血病」检索，对应国际通用词 leukemia
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 09:55，每 5 分钟自动同步正在招募不适用中国有中心NCT06076226
A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation
China
年龄 5 Years – 90 Years
Zhejiang University
正在招募I 期中国有中心NCT06690827
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN
China
年龄 18 Years – 75 Years
Chongqing Precision Biotech Co., Ltd
正在招募III 期中国有中心NCT06802718
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
China
年龄 18 Years – 70 Years
Peking University People's Hospital
正在招募早期 I 期中国有中心NCT06633341
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
China
年龄 不限 – 不限
Zhejiang University
正在招募II 期中国有中心NCT07509086
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
China
年龄 18 Years – 80 Years
The First Hospital of Jilin University
正在招募II 期 / III 期中国有中心NCT05404906
AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission
China
年龄 18 Years – 64 Years
The First Affiliated Hospital of Soochow University
正在招募III 期中国有中心NCT06345365
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
China
年龄 18 Years – 75 Years
Zhongnan Hospital
正在招募I 期中国有中心NCT07014449
Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia
China
年龄 18 Years – 不限
Hangzhou Weben Pharma Co., Ltd
正在招募III 期中国有中心NCT05991908
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
China
年龄 16 Years – 55 Years
Shanghai Jiao Tong University School of Medicine
正在招募不适用中国有中心NCT06458257
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
China
年龄 18 Years – 65 Years
Ruijin Hospital
正在招募不适用中国有中心NCT06328179
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
China
年龄 18 Years – 60 Years
Huai'an First People's Hospital
正在招募I 期 / II 期中国有中心NCT06948981
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
China
年龄 18 Years – 75 Years
Grit Biotechnology